• About Us
    • What We Do
    • Our Story
    • Board Members
    • Management Team
  • Products
    • COVID-19 Response
      • COVID-19 Home Test
      • QIAreach COVID
      • ellume·lab COVID Tests
      • Swab+Drop COVID Self-Swab Kit
    • Consumer Products
      • COVID-19 Home Test
      • Influenza Home Test
    • Professional Products
      • ellume·lab
      • Swab+Drop Self-Swab Kit
    • Global Public Health Solutions
      • COVID-19
      • Tuberculosis
      • Pandemic Influenza
  • Our Tech
  • Media
  • Contact
  • About Us
    • What We Do
    • Our Story
    • Board Members
    • Management Team
  • Products
    • COVID-19 Response
      • COVID-19 Home Test
      • QIAreach COVID
      • ellume·lab COVID Tests
      • Swab+Drop COVID Self-Swab Kit
    • Consumer Products
      • COVID-19 Home Test
      • Influenza Home Test
    • Professional Products
      • ellume·lab
      • Swab+Drop Self-Swab Kit
    • Global Public Health Solutions
      • COVID-19
      • Tuberculosis
      • Pandemic Influenza
  • Our Tech
  • Media
  • Contact

ABC Radio Brisbane Interview with Ellume CEO, Dr Sean Parsons

31 August 2020, Kelly Higgins-Devine

Ellume Founder, CEO and Managing Director Dr Sean Parsons was recently interviewed by ABC Brisbane Radio’s Kelly Higgins-Devine about how its innovative digital diagnostics are responding to the COVID-19 pandemic.

This interview originally appeared on ABC Brisbane radio, “Mornings” program on 31st August 2020. Listen to the full Mornings episode here on the ABC Radio Brisbane website.

Recent Posts
  • BBC World Service Radio Brisbane Interview with Ellume CEO
  • FDA authorizes Ellume COVID-19 Home Test as First Over-the-Counter Fully At-Home Diagnostic Test
  • Ellume’s COVID-19 Home Test shows 96% accuracy in multi-site US clinical study
  • Palaszczuk Government boosts manufacturing capability for Ellume’s world-class COVID-19 rapid tests
  • ABC Radio “The Money” Interview with Ellume CEO, Dr Sean Parsons
Archives

Brisbane biotech company to send millions of COVID-19 tests to US

Previous thumb

Ellume announces high-performance test for active COVID-19 infection

Next thumb
Scroll

ellume logo white

ABN 13 141 767 660
57 Didsbury Street,
East Brisbane, Queensland 4169
Australia

MENU

Home
About Us
COVID-19 Response
Consumer Products
Professional Products
Global Public Health Solutions
Our Tech
Media

CONTACT US

1800 001 120
+61 7 3393 1448
General Enquiries
Privacy Policy
Whistleblower Policy

Some Ellume products are pending regulatory clearance – NOT AVAILABLE FOR SALE © Ellume Limited 2020